Plain-English translation of NCT07510087 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is designed to understand how glaucoma—an eye condition that can lead to vision loss—affects the everyday lives and wellbeing of people living with it. Researchers will ask you to fill out questionnaires about how glaucoma impacts your daily activities, emotions, and quality of life. They'll compare your answers before and after you start or undergo glaucoma treatment to see how the condition and its management affect your overall wellbeing.
Doctors have good tools to treat glaucoma and slow vision loss, but they want to better understand how the disease—and the treatments for it—actually affect patients' lives. This study will help doctors recognize which aspects of living with glaucoma matter most to patients, so they can provide more complete, patient-centered care.
You likely qualify if…
You likely don't qualify if…
You will complete questionnaires about how glaucoma affects your daily life, work, relationships, and emotional wellbeing. You'll fill out these same questionnaires again 3 to 6 months after you start a new glaucoma treatment or have glaucoma surgery. The study team will compare your responses to understand how treatment affects your quality of life. Your participation helps researchers learn what matters most to patients like you.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Enrollment target
~5,000 participants
Started
December 2024
Primary completion
November 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Marc Toeteberg-Harms, MD
Marc Toeteberg-Harms
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.